Avonoid contains Micronised Diosmin + Hesperidin. Avonoid uses:

It is indicated in the treatment of venous disease, ie. chronic venous disaese & hemorrhoidal disease.

Brand Name: Avonoid
Generic: Micronised Diosmin + Hesperidin
Weight: 450 mg+50 mg
Type: Tablet
Therapeutic Class: Phlebotonic & Vascular protecting preparation
Manufacturer: Unimed Unihealth MFG. Ltd
Price: 11.20
Last Updated: November 19, 2020 at 6:15 pm


Diosmin and Hesperidin is a phlebotonic drug and a vascular protecting agent. It reinforces venous tone by prolonging the activity of parietal noradrenaline. Thus Diosmin and Hesperidin decreases venous capacitance, venous distensibility, and venous emptying time.

Diosmin and Hesperidin protects the microcirculation by fighting the microcirculation damaging process; It combats venous inflammation by decreasing leukocyte activation, and as a consequence, by inhibiting the release of inflammatory mediators, principally free radicals and prostaglandin. Thus Diosmin and Hesperidin normalizes capillary permeability and strengthens capillary resistance. 

Diosmin and Hesperidin acts on the lymphatic system, It improves lymphatic drainage by increasing lymph flow and lymph oncotic pressure.



Avonoid contains Micronised Diosmin + Hesperidin 450 mg+50 mg. Avonoid Dosage:


  • Acute attack: 6 tablets daily for the 1st 4 days followed by 4 tablets daily for the next 3 days.
  • Chronic haemorrhoids: 2 tablets daily.

Chronic venous disease: 2 tablets daily. The tablets should be taken at meal times.


Side Effects

Possible side-effects are cutaneous allergies, gastrointestinal disorders, headaches and flushes.


Acute hemorrhoidal attack: If the hemorrhoid symptoms do not disappear within 15 days, the patient should ask the doctor for advice. Venous circulation disorders: The most effective way of giving this treatment is in combination with a healthy lifestyle. Avoid exposure to the sun, heat, excessive standing and being overweight. Walking and wearing special support stockings stimulate blood circulation.



Pregnancy Lactation use

Pregnancy: There were no teratogenic observations in human studies. It is, however, recommended that it should not be administered during the first three months of pregnancy.

Lactation: In the absence of data concerning the diffusion of the drug substance in the breast milk, breast feeding is not recommended during treatment.


It is contra-indicated in patients, who have shown hypersensitivity to any of the substances present in the drug.

Special Warning


Acute Overdose

No overdosage symptoms have been observed.

Interaction with other Medicine


Storage Condition

Store at a cool & dry place, protect from light & moisture.

Avonoid Tablet price in Bangladesh 11.20